Syndax Pharmaceuticals SNDX Amortization Of Financing Costs
Amortization Of Financing Costs at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's amortization of financing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's amortization of financing costs?
- Syndax Pharmaceuticals (SNDX) reported amortization of financing costs of $56K in Q1 2026.
- How has Syndax Pharmaceuticals's amortization of financing costs changed year-over-year?
- Syndax Pharmaceuticals's amortization of financing costs decreased by 50.0% year-over-year, from $112K to $56K.